Combined results of NBS programs in Australia, Germany and USA report an incidence of 1:750,0001:2,000,000 [55], but numbers on prevalence are scarce since CPT2 deficiency has not been introduced in most NBS panels
Xiao Y, Zhai Q, Zhang H, Chen W, Hill C
Start your intake Current FDA Approval Status for Oral Tirzepatide As of 2024, the FDA has approved tirzepatide in injectable form under the brand name Zepbound for chronic weight management and Mounjaro for type 2 diabetes
While its naturally present in certain foods and available as oral supplements, B12 injections are increasingly being preferred for their efficacy and direct delivery
doi: 10.1212/WNL.0000000000003849 178 UngaroRMehandruSAllenPBPeyrin-BirouletLColombelJ